New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aeglea BioTherapeutics, Inc.
AGLE
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

49M

Biotechnology

12.01USD

Shape0.75 ( 6.66%)
Market Closed (as of Nov 27, 21:00 EDT)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-27%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

50%

Quote Panel

Shape
Updated February 7, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    48.63M


  • Shares Outstanding

    4.05M


  • Share in Float

    1.92M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    12.01


  • Average Volume

    59537


  • Beta

    2.572


  • Range

    2.66-24.0


  • Industry

    Biotechnology


  • Website

    https://www.aeglea.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

AGLE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$20M

ShapeNaN%

2024-Revenue

$1.56

Shape83%

2024-EPS

$4M

Shape78%

2024-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Wells Fargo

upgrade

Previous: Equal-Weight

2022-10-28

Now: Overweight

Piper Sandler

upgrade

Previous: Neutral

2022-10-27

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-7.75
vs -8.50

Q1.22

arrow
arrow

N/A

-9.25
vs -7.00

Q2.22

arrow
arrow

N/A

-6.75
vs -2.50

Q3.22

arrow
arrow

N/A

-4.75
vs -7.75

Q4.22

arrow
arrow

N/A

-4.50
vs -7.75

Q1.23

arrow
arrow

N/A

-5.00
vs -9.25

Q2.23

arrow
arrow

N/A

-41.50
vs -6.75

Q3.23

arrow
arrow

N/A

-3.43
vs -4.75

Q4.23

arrow
arrow

N/A

-27679442.00
vs -4.50

Q1.24

arrow
arrow

+132%

1.58
vs -5.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

NA

3.6M  vs NA

Q1.22

arrow
arrow

NA

1.4M  vs NA

Q2.22

arrow
arrow

-95%

625K  vs 13.7M

Q3.22

arrow
arrow

-88%

174K  vs 1.4M

Q4.22

arrow
arrow

-95%

168K  vs 3.6M

Q1.23

arrow
arrow

-85%

198K  vs 1.4M

Q2.23

arrow
arrow

+10%

688K  vs 625K

Q3.23

arrow
arrow

-100%

NA  vs 174K

Q4.23

arrow
arrow

+3172%

5.5M  vs 168K

Q1.24

arrow
arrow

+448%

1.1M  vs 198K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-37%

-0.37
vs -0.27

Q1.23

arrow
arrow

-55%

-0.55
vs -0.37

Q2.23

arrow
arrow

+105%

1.05
vs -0.55

Q3.23

arrow
arrow

+16%

0.16
vs 1.05

Q4.23

arrow
arrow

-34%

-0.34
vs 0.16

Q1.24

arrow
arrow

-29%

-0.29
vs -0.34

Q2.24

arrow
arrow

-10%

-0.10
vs -0.29

Q3.24

arrow
arrow

-21%

-0.21
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

79

79
vs 86

-8%

Q2.22

arrow
arrow

61

61
vs 79

-23%

Q3.22

arrow
arrow

51

51
vs 61

-16%

Q4.22

arrow
arrow

50

50
vs 51

-2%

Q1.23

arrow
arrow

42

42
vs 50

-16%

Q2.23

arrow
arrow

42

42
vs 42

NA

Q3.23

arrow
arrow

3

3
vs 42

-93%

Q1.24

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News